LA JOLLA PHARMACEUTICAL CO·4

Jun 2, 3:07 PM ET

Gillespie Deirdre 4

4 · LA JOLLA PHARMACEUTICAL CO · Filed Jun 2, 2010

Insider Transaction Report

Form 4
Period: 2010-05-28
Gillespie Deirdre
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (right to buy)

    2010-05-28+4,000,0004,000,000 total
    Exercise: $0.06Exp: 2020-05-28Common Stock (4,000,000 underlying)
Footnotes (1)
  • [F1]The stock options vest and become exercisable monthly over the next three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION